Shrinking lung in primary Sjögren's syndrome
✍ Scribed by Antonio Tavoni; Claudio Vitali; Giovanna Cirigliano; Sabrina Frigelli; Giulia Stampacchia; Stefano Bombardieri
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 270 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Primary Sjögren's syndrome (SS) is an autoimmune disease characterized by activation of minor salivary gland (MSG) epithelial cells and B and T lymphocytic infiltrates. These findings have long encouraged the hypothesis that a persistent viral infection of the MSG epitheli
## Objective: There is no effective treatment for patients with primary sjögren's syndrome (ss). since tumor necrosis factor alpha (tnf alpha) could be a key element in the pathogenesis of primary ss, we conducted a multicenter, randomized, double-blind, placebo-controlled trial to evaluate the eff
## Abstract Sera from 48 patients with Sjögren's syndrome were examined for immune complexes by the Raji cell assay. There was no correlation between levels of immune complexes and the degree of lymphocytic infiltration of the labial salivary glands. Serum complement levels were normal. Five patien